SEC Form 3 
FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 	  
OMB APPROVAL
OMB Number:	3235-0104	
Estimated average burden	
hours per response:	0.5	

	
1. Name and Address of Reporting Person*
Arrington Guy	

(Last)	(First)	(Middle)	
5599 SAN FELIPE, 17TH FLOOR	

(Street) 
HOUSTON	TX	77056	

(City)	(State)	(Zip)	
	2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2018 	3. Issuer Name and Ticker or Trading Symbol 
SCHLUMBERGER LIMITED/NV [ SLB ] 		
		4. Relationship of Reporting Person(s) to Issuer 
(Check all applicable) 
	Director		10% Owner	
X	Officer (give title below)		Other (specify below)	
VP Ops Planning & Resource Mgt	
	5. If Amendment, Date of Original Filed (Month/Day/Year)				
			6. Individual or Joint/Group Filing (Check Applicable Line) 
X	Form filed by One Reporting Person	
	Form filed by More than One Reporting Person	
	
Table I - Non-Derivative Securities Beneficially Owned	
1. Title of Security (Instr. 4) 	2. Amount of Securities Beneficially Owned (Instr. 4) 	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 	4. Nature of Indirect Beneficial Ownership (Instr. 5) 	
Common Stock, $0.01 Par Value Per Share	811.935	I	SL Int'l PS Plan	
Common Stock, $0.01 Par Value Per Share	7,236	I	by Trust(1) 	
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) 	
1. Title of Derivative Security (Instr. 4) 	2. Date Exercisable and Expiration Date (Month/Day/Year)	3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 	4. Conversion or Exercise Price of Derivative Security 	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 	6. Nature of Indirect Beneficial Ownership (Instr. 5) 	
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares				
Incentive Stock Option (Right to Buy)	01/21/2015	01/21/2020	Common Stock, $0.01 Par Value Per Share	1,000	68.505	D		
Incentive Stock Option (Right to Buy)	10/21/2015	10/21/2020	Common Stock, $0.01 Par Value Per Share	980	64.225	D		
Incentive Stock Option (Right to Buy)	01/19/2017	01/19/2022	Common Stock, $0.01 Par Value Per Share	2,772	72.11	D		
Incentive Stock Option (Right to Buy)	04/18/2018	04/18/2023	Common Stock, $0.01 Par Value Per Share	1,409	70.925	D		
Incentive Stock Option (Right to Buy)	04/16/2019	04/16/2024	Common Stock, $0.01 Par Value Per Share	994	100.555	D		
Incentive Stock Option (Right to Buy)	04/16/2020	04/16/2025	Common Stock, $0.01 Par Value Per Share	1,090	91.74	D		
Incentive Stock Option (Right to Buy)	04/20/2021	04/20/2026	Common Stock, $0.01 Par Value Per Share	1,241	80.525	D		
Incentive Stock Option (Right to Buy)	01/19/2022	01/19/2027	Common Stock, $0.01 Par Value Per Share	1,144	87.38	D		
Non-Qualified Stock Option (Right to Buy)	(2) 	04/18/2023	Common Stock, $0.01 Par Value Per Share	18,591	70.925	D		
Non-Qualified Stock Option (Right to Buy)	(3) 	04/16/2024	Common Stock, $0.01 Par Value Per Share	19,006	100.555	D		
Non-Qualified Stock Option (Right to Buy)	(4) 	04/16/2025	Common Stock, $0.01 Par Value Per Share	22,910	91.74	D		
Non-Qualified Stock Option (Right to Buy)	(5) 	04/20/2026	Common Stock, $0.01 Par Value Per Share	28,759	80.525	D		
Non-Qualified Stock Option (Right to Buy)	(6) 	01/19/2027	Common Stock, $0.01 Par Value Per Share	13,856	87.38	D		
Non-Qualified Stock Option (Right to Buy)	01/21/2012	01/21/2020	Common Stock, $0.01 Par Value Per Share	1,999	68.505	D		
Non-Qualified Stock Option (Right to Buy)	10/21/2015	10/21/2020	Common Stock, $0.01 Par Value Per Share	18,530	64.225	D		
Non-Qualified Stock Option (Right to Buy)	01/19/2017	01/19/2022	Common Stock, $0.01 Par Value Per Share	17,228	72.11	D		
RSU (Restricted Stock Unit)	(7) 	(7) 	Common Stock, $0.01 Par Value Per Share	3,800	(8)	D		
RSU (Restricted Stock Unit)	(9) 	(9) 	Common Stock, $0.01 Par Value Per Share	10,000	(8)	D		
Explanation of Responses:	
1. Held by the CraveblueH20 trust, of which the reporting person is the trustee and a beneficiary.	
2. 4,000 options under this grant became exercisable annually beginning April 18, 2014. The final 2,591 options under this grant become exercisable April 18, 2018.	
3. 4,000 options under this grant become exercisable annually beginning April 16, 2015. The final 3,006 options under this grant become exercisable April 16, 2019.	
4. 4,800 options under this grant become exercisable annually beginning April 16, 2016. The final 3,710 options under this grant become exercisable April 16, 2020.	
5. 6,000 options under this grant become exercisable annually beginning April 20, 2017. The final 4,759 options under this grant become exercisable April 20, 2021.	
6. 3,000 options under this grant become exercisable annually beginning January 19, 2017. The final 1,856 options under this grant become exercisable January 19, 2022.	
7. The restricted stock unit award was granted on January 19, 2017 and vests 100% on January 19, 2020.	
8. Each restricted stock unit represents the right to receive, at settlement, one (1) share of common stock.	
9. The restricted stock unit award was granted July 20, 2016 and vests 100% on July 20, 2019.	
	/s/ Matthew Rinegar, Attorney-in-Fact	02/12/2018	
	** Signature of Reporting Person	Date	
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).	
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.